89650 Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices 

authorizes the committee to operate 

until November 10, 2026 

A copy of the ACHDNC charter is 

available on the ACHDNC website at 

https://www.hrsa.gov/advisorycommittees/heritable-disorders/ 

index.html. A copy of the charter also 

can be obtained by accessing the FACA 

database that is maintained by the 

Committee Management Secretariat 

under the General Services 

Administration. The website address for 

the FACA database is http:// 

www.facadatabase.gov/. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–26198 Filed 11–12–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Science 

Advisory Board for Biosecurity. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting should notify the Contact 

Person listed below in advance of the 

meeting. The meeting will be videocast 

and can be accessed from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov/). 

Name of Committee: National Science 

Advisory Board for Biosecurity. 

Date: November 21, 2024. 

Time: 1:00 p.m. to 2:00 p.m. 

Agenda: The National Science Advisory 

Board for Biosecurity meeting will include a 

review of a new charge to the committee and 

discussion of next steps for the committee. 

Address: National Institutes of Health, 

6705 Rockledge Drive, Suite 630, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Meeting Access: https://osp.od.nih.gov/ 

policies/national-science-advisory-board-forbiosecurity-nsabb#tab3/. 

Contact Person: Cari Young, ScM, Office of 

Science Policy, Office of the Director, 

National Institutes of Health, 6705 Rockledge 

Drive, Suite 630, Bethesda, MD 20892, 301– 

496–9838, SciencePolicy@od.nih.gov. 

This notice is being published less 

than 15 days from the meeting date due 

to exceptional circumstances which did 

not allow sufficient time to submit the 

notice within the typical lead time 

required for publication. The National 

Science Advisory Board for Biosecurity 

meeting will include review of a new 

charge to the committee that, in keeping 

with the committee’s charter, is of vital 

importance to biomedical research, 

public health, and national security. If 

the meeting is not held on November 21, 

2024, committee members and 

participants with the requisite scientific, 

technical, public health, biodefense, and 

national security expertise will be 

unable to participate due to scheduling 

conflicts. Information is also available 

on the Institute’s/Center’s home page: 

https://osp.od.nih.gov/policies/nationalscience-advisory-board-for-biosecuritynsabb#tab3/, where an agenda and any 

additional information for the meeting 

will be posted when available. 

Dated: November 7, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–26268 Filed 11–12–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Acquired 

Immunodeficiency Syndrome Research 

Committee (AIDS) Special Emphasis Panel. 

Date: December 5, 2024. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Samita S. Andreansky, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71, 

Rockville, MD 20892, 240–669–2915, 

samita.andreansky@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 6, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26187 Filed 11–12–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Strategic 

Preparedness and Response 

National Advisory Committee on 

Children and Disasters Public Meeting 

AGENCY: Administration for Strategic 

Preparedness and Response (ASPR), 

U.S. Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The National Advisory 

Committee on Children and Disasters 

(NACCD or the Committee) will conduct 

a public meeting (virtual) to discuss 

potential recommendations to the HHS 

Secretary and ASPR regarding 

challenges, opportunities, and priorities 

for national public health and medical 

preparedness, response, and recovery 

specific to the needs of children and 

their families in disasters. 

DATES: The public meeting (virtual) will 

be held December 4, 2024. 

ADDRESSES: A more detailed agenda and 

meeting registration link will be 

available on the NACCD meeting 

website at https://aspr.hhs.gov/ 

AboutASPR/WorkingwithASPR/ 

BoardsandCommittees/Pages/NACCD/ 

Public-Meetings.aspx. 

FOR FURTHER INFORMATION CONTACT: 

Zhoowan Jackson, NACCD Designated 

Federal Officer, Administration for 

Strategic Preparedness and Response 

(ASPR), U.S. Department of Health and 

Human Services (HHS), Washington, 

DC; 202–205–4217, NACCD@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

NACCD is established by section 2811A 

of the Public Health Service Act (42 

U.S.C. 300hh-10b) as amended by the 

Pandemic and All Hazards Preparedness 

and Advancing Innovation Act and 

governed by the provisions of the 

Federal Advisory Committee Act (5 

U.S.C. app.). The statute directs the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices 89651 

NACCD to evaluate issues and programs 

and provide findings, advice, and 

recommendations to the HHS Secretary 

and ASPR to support and enhance allhazards public health and medical 

preparedness, response, and recovery 

aimed at meeting the unique needs of 

children and their families across the 

entire spectrum of their wellbeing. The 

HHS Secretary has formally delegated 

authority to operate the NACCD to 

ASPR. 

Procedures for Public Participation: 

Members of the public may attend the 

meeting via a toll-free phone number or 

Zoom teleconference, which requires 

pre-registration. The meeting link to 

pre-register will be posted on the 

NACCD meeting website. Members of 

the public may provide written 

comments or submit questions for 

consideration to the NACCD at any time 

via email to NACCD@hhs.gov. Members 

of the public are also encouraged to 

provide comments after the meeting. 

The NACCD invites those who are 

involved in or represent a relevant 

industry, academia, health profession, 

health care consumer organization, or 

state, tribal, territorial, or local 

government to request up to four 

minutes to address the committee live 

via Zoom. Requests to provide remarks 

to the NACCD during the public 

meeting must be sent to NACCD@

hhs.gov at least 10 days prior to the 

meeting along with a brief description of 

the topic. We would specifically like to 

request inputs from the public on the 

future of pediatric disaster care 

networks and any barriers to success as 

well as other challenges, opportunities, 

and strategic priorities for national 

public health and medical 

preparedness, response, and recovery 

specific to the needs of children and 

their families in disasters. 

The Administrator and Assistant 

Secretary for Preparedness and 

Response of ASPR, Dawn O’Connell, 

having reviewed and approved this 

document, authorizes Adam DeVore, 

who is the Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Adam DeVore, 

Federal Register Liaison, Administration for 

Strategic Preparedness and Response. 

[FR Doc. 2024–25886 Filed 11–12–24; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Strategic 

Preparedness and Response 

National Advisory Committee on 

Individuals With Disabilities and 

Disasters, National Advisory 

Committee on Seniors and Disasters, 

and the National Biodefense Science 

Board; Call for Member Nominees 

AGENCY: Administration for Strategic 

Preparedness and Response (ASPR), 

U.S. Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: ASPR, in HHS, is currently 

seeking applications from qualified 

individuals for memberships on the 

following national advisory committees 

(vacancies): The National Advisory 

Committee on Individuals with 

Disabilities and Disasters (NACIDD) (7 

vacancies); the National Advisory 

Committee on Seniors and Disasters 

(NACSD) (7 vacancies); and the National 

Biodefense Science Board (NBSB) (7 

vacancies). The HHS Secretary will 

appoint new voting members. 

DATES: Nomination Period: The rolling 

application period is from November 12, 

2024–January 11, 2025, at 11:59 p.m. 

eastern standard time. 

FOR FURTHER INFORMATION CONTACT: 

Sylvia Sosa, Designated Federal Official, 

NACIDD, ASPR, HHS, NACIDD@

hhs.gov, Office: 202–843–3876; Dr. 

Maxine Kellman, Designated Federal 

Official, NACSD, ASPR, HHS, NACSD@

hhs.gov, Office: 202–260–0447; LCDR 

Cliffon Smith, Designated Federal 

Official, NBSB, ASPR, HHS, NBSB@

hhs.gov, Office: (202) 868–9352. 

SUPPLEMENTARY INFORMATION: The 

National Advisory Committees (NAC) 

program includes a group of Federal 

advisory committees authorized to 

provide advice and recommendations to 

the HHS Secretary. The committees are 

managed by ASPR, with an additional 

delegation of authority that allows the 

Administrator and Assistant Secretary 

for Preparedness and Response (the 

ASPR) to request and receive 

recommendations on behalf of the 

Secretary. 

The nationally renowned subject 

matter experts appointed to the HHS 

national advisory committees advise the 

HHS Secretary and the ASPR by holding 

working groups and public meetings 

throughout the year to address high 

priority issues and develop 

recommendations. These committees 

bring timely analysis, crucial 

perspectives, and new ideas to ASPR’s 

strategies and programs. 

The committees listed below enhance 

public health emergency preparedness 

and response by coordinating federal 

efforts for the prevention, preparedness, 

response, and recovery from public 

health emergencies or medical disasters. 

They advise on strategic planning and 

provide expert guidance to lawmakers, 

the HHS Secretary, and other decisionmakers. The ASPR NAC includes: The 

NACIDD, the NACSD, and the NBSB. 

Voting members shall not be full-time 

or permanent part-time federal 

employees but shall be appointed by the 

HHS Secretary as Special Government 

Employees (5 U.S.C. 3109) in an unpaid 

position. A voting member of the 

committees shall serve for a term of 

three years; the HHS Secretary may also 

adjust the terms of appointees. A voting 

member may serve not more than three 

terms on the committees, and not more 

than two of such terms may be served 

consecutively. A member may serve 

after the expiration of his/her term until 

a successor has been appointed. 

Applicants to those positions may be 

nominated by a relevant organization or 

may nominate themselves based on 

their expertise within the following 

stakeholder groups: Industry, academia, 

health care consumer organizations, and 

organizations representing other 

appropriate stakeholders. Please visit 

the ASPR’s website at: https://

aspr.hhs.gov/AboutASPR/Workingwith

ASPR/BoardsandCommittees/Pages/ 

default.aspx for all application 

submission information, additional 

information regarding the qualifications 

expected for applicants, and application 

instructions. 

NACIDD 

Authority: The NACIDD is required by 

section 2811C of the Public Health 

Service (PHS) Act (42 U.S.C. 300hh– 

10d), as amended by the Pandemic and 

All-Hazards Preparedness and 

Advancing Innovation Act (PAHPAIA), 

Public Law 116–22. 

Description of Duties: The NACIDD 

evaluates issues and programs and 

provides findings, advice, and 

recommendations to the HHS Secretary 

and the ASPR, in accordance with the 

Federal Advisory Committee Act 

(FACA), to support and enhance allhazards public health and medical 

preparedness, response activities, and 

recovery, aimed at meeting the unique 

needs of individuals with disabilities 

across the entire spectrum of well-being. 

The NACIDD shall (1) provide advice 

and consultation with respect to 

activities carried out in regard to at-risk 

individuals pursuant to section 2814 of 


lotter on DSK11XQN23PROD with NOTICES1